Gaudium IVF approves ₹15 crore hospital in Lucknow

1 min read     Updated on 25 Jun 2026, 02:50 PM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Gaudium IVF & Women Health received board approval to establish Gaudium Women Hospital in Lucknow, Uttar Pradesh, with an estimated project cost of ₹15,00,00,000. The agreement involves a 30-year land lease with Mrs. Abhilasha Singh and M/s. Abhilasha Enterprises, featuring a 15-year lock-in period and a revenue-sharing model requiring a 10% payout of net revenue and a ₹3,00,00,000 security deposit.

powered bylight_fuzz_icon
43924439

*this image is generated using AI for illustrative purposes only.

Gaudium IVF & Women Health has secured board approval to establish Gaudium Women Hospital in Lucknow, Uttar Pradesh, through a long-term arrangement with property owners. The project entails an estimated cost of ₹15,00,00,000 for development, construction, fit-outs, and medical infrastructure, marking a significant expansion in the company's healthcare footprint.

Board-Approved Expansion

The board approved the proposal for the establishment, development, operation, and management of the facility at a meeting held on June 25, 2026. The agreement involves a land lease arrangement with Mrs. Abhilasha Singh and M/s. Abhilasha Enterprises, who are not related to the promoter or promoter group.

Key Financial and Operational Details

The project is structured around a 30-year lease with a 15-year lock-in period. The financial terms include a revenue-sharing model and a security deposit.

Parameter Details
Facility Name Gaudium Women Hospital
Location Lucknow, Uttar Pradesh
Estimated Project Cost ₹15,00,00,000
Lease Tenure 30 years
Lock-in Period 15 years
Security Deposit ₹3,00,00,000
Revenue Share 10% of net revenue

The company will pay the landowner 10% of the net revenue generated from the hospital monthly, plus applicable taxes. A security deposit of ₹3,00,00,000 will be adjusted against the revenue share payable until fully recovered by the company. Upon full recovery, the company will pay the landowner's revenue share on a monthly basis.

Historical Stock Returns for Gaudium IVF & Women Health

1 Day5 Days1 Month6 Months1 Year5 Years
-1.99%+3.95%-5.60%+35.35%+35.35%+35.35%

What is the projected timeline for the construction and operational launch of the Lucknow facility?

How does the company plan to finance the ₹15 crore project cost, and will it impact current liquidity?

What revenue targets does Gaudium anticipate for the Lucknow hospital to offset the 10% revenue share?

Gaudium IVF & Women Health
View Company Insights
View All News
like18
dislike

Gaudium IVF promoters report no share encumbrance in FY26

1 min read     Updated on 23 Jun 2026, 03:52 AM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Gaudium IVF and Women Health Limited disclosed that its promoters and promoter group have not created any encumbrance over the company's shares during the financial year ended March 31, 2026. The declaration, submitted to the stock exchanges on April 06, 2026, confirms that no shares held directly or indirectly by the promoters were pledged or otherwise encumbered in FY26.

powered bylight_fuzz_icon
43275460

*this image is generated using AI for illustrative purposes only.

Gaudium IVF and Women Health Limited has disclosed that its promoters and promoter group have not created any encumbrance over the company's shares during the financial year ended March 31, 2026. This declaration, submitted to the stock exchanges on April 06, 2026, confirms that no shares held directly or indirectly by the promoters were pledged or otherwise encumbered in FY26.

The disclosure was made in compliance with Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Dr. Manika Khanna, a promoter of the company, confirmed that neither the promoters, the promoter group, nor any persons acting in concert had made any encumbrance over the shares during the specified period.

The filing identified the individuals and entities that constitute the promoter and promoter group. The list includes three promoters and ten members of the promoter group, comprising individuals and private limited companies associated with the founders.

Promoter and Promoter Group Details

The following table outlines the members of the promoter and promoter group as per the disclosure:

Sr. No. Name Category
1. Dr. Manika Khanna Promoter
2. Dr. Peeyush Khanna Promoter
3. Mr. Vishad Khanna Promoter
4. Dr. Gautam Anand Promoter Group
5. Dr. Rajinder Kumar Anand Promoter Group
6. Mrs. Malini Anand Promoter Group
7. Ms. Shobhini Khanna Promoter Group
8. Mrs. Sucharita Malhotra Promoter Group
9. Mrs. Ritambhara Dewan Promoter Group
10. M/s. EKK Hospitality Private Limited Promoter Group
11. M/s. EKK Global Private Limited Promoter Group
12. M/s. Gaudium Foundation Promoter Group
13. M/s. Gaudium Signature Lab Promoter Group

The document was signed by Naveen Kumar, Company Secretary and Compliance Officer of Gaudium IVF and Women Health Limited. The company requested the exchanges to place the information on record.

Historical Stock Returns for Gaudium IVF & Women Health

1 Day5 Days1 Month6 Months1 Year5 Years
-1.99%+3.95%-5.60%+35.35%+35.35%+35.35%

How might the absence of share encumbrance impact Gaudium IVF's ability to secure future financing for expansion?

What are the strategic growth plans for Gaudium IVF following this clean financial disclosure?

How will this unencumbered status influence investor confidence and stock performance in the upcoming quarters?

Gaudium IVF & Women Health
View Company Insights
View All News
like20
dislike

More News on Gaudium IVF & Women Health

1 Year Returns:+35.35%